John R Dabous - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

BMJ Open|October 12, 2022

Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: a retrospective cohort studyKristen A Morin, John R Dabous, Frank Vojtesek, et al.

Biochemical and Biophysical Research Communications|November 19, 2011

Preparation and characterization of cobalt-substituted anthrax lethal factorCrystal E Säbel, Ryan Carbone, John R Dabous, et al.

Cureus|December 2, 2021

Evidence of Increased Age and Sex Standardized Death Rates Among Individuals Who Accessed Opioid Agonist Treatment Before the Era of Synthetic Opioids in Ontario, CanadaKristen A Morin, Frank Vojtesek, Shreedhar Acharya, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

BMJ Open|October 12, 2022

Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: a retrospective cohort studyKristen A Morin, John R Dabous, Frank Vojtesek, et al.

Biochemical and Biophysical Research Communications|November 19, 2011

Preparation and characterization of cobalt-substituted anthrax lethal factorCrystal E Säbel, Ryan Carbone, John R Dabous, et al.

Cureus|December 2, 2021

Evidence of Increased Age and Sex Standardized Death Rates Among Individuals Who Accessed Opioid Agonist Treatment Before the Era of Synthetic Opioids in Ontario, CanadaKristen A Morin, Frank Vojtesek, Shreedhar Acharya, et al.

Pageof 1